Cancer Family
Head and Neck Neuroendocrine Neoplasm
CI-CAN-00000194Explore in graph →
Non-malignant27 active trials3 approved drugs18 evidence items
- NCIt
- C188222
Loading cancer entity…
Cancer Family
CI-CAN-00000194Explore in graph →
Clinical trials
110 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04211337 | A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer(LIBRETTO-531) | active not recruiting | Phase 3 | 291 | Loxo Oncology, Inc.INDUSTRY | 20 | Mar 19, 2026 | clinicaltrials |
| NCT07383246 | CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC(CAST-MTC) | recruiting | Phase 3 | 150 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 |
| Feb 3, 2026 |
| clinicaltrials |
Data updated 22 days agoSource updated Mar 19, 2026source: clinicaltrials